DrugMapper


Display Options: Drug type Therapeutic Area Route of administration Mechanism of Action Indication Status		Total: 968


Antibody Approved DERMATOLOGY INJECTION Carcinoma, Pancreatic Ductal; Endometrial Neoplasms; Fallopian Tube Neoplasms; Glioma; HIV Infections; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Lymphoma; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Multiple Myeloma; Myelodysplastic Syndromes; Neoplasm Metastasis; Nerve Sheath Neoplasms; Neuroblastoma; Peritoneal Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retroperitoneal Neoplasms; Skin Neoplasms; Uterine Cervical Neoplasms; Adenocarcinoma; Basal Cell Nevus Syndrome; Biliary Tract Neoplasms; Breast Neoplasms; Carcinoid Tumor; Carcinoma; Carcinoma, Basal Cell; Carcinoma, Merkel Cell; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Colonic Neoplasms; Colorectal Neoplasms; Esophageal Neoplasms; Gastrointestinal Stromal Tumors; Gliosarcoma; Histiocytoma, Malignant Fibrous; Hodgkin Disease; Inflammatory Breast Neoplasms; Liposarcoma; Meningioma; Nasopharyngeal Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Pituitary Neoplasms; Prostatic Neoplasms; Rectal Neoplasms; Retroviridae Infections; Salivary Gland Neoplasms; Sarcoma, Kaposi; Sarcoma, Synovial; Stomach Neoplasms; Thyroid Neoplasms; Urinary Bladder Neoplasms; Adenocarcinoma of Lung; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Glioblastoma; Head and Neck Neoplasms; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Mesothelioma; Prostatic Neoplasms, Castration-Resistant; Sarcoma; Small Cell Lung Carcinoma; Urogenital Neoplasms; Melanoma; Neoplasms Cytotoxic T-lymphocyte protein 4 inhibitor

Antibody

Approved

DERMATOLOGY

INJECTION

Carcinoma, Pancreatic Ductal; Endometrial Neoplasms; Fallopian Tube Neoplasms; Glioma; HIV Infections; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Lymphoma; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Multiple Myeloma; Myelodysplastic Syndromes; Neoplasm Metastasis; Nerve Sheath Neoplasms; Neuroblastoma; Peritoneal Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retroperitoneal Neoplasms; Skin Neoplasms; Uterine Cervical Neoplasms; Adenocarcinoma; Basal Cell Nevus Syndrome; Biliary Tract Neoplasms; Breast Neoplasms; Carcinoid Tumor; Carcinoma; Carcinoma, Basal Cell; Carcinoma, Merkel Cell; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Colonic Neoplasms; Colorectal Neoplasms; Esophageal Neoplasms; Gastrointestinal Stromal Tumors; Gliosarcoma; Histiocytoma, Malignant Fibrous; Hodgkin Disease; Inflammatory Breast Neoplasms; Liposarcoma; Meningioma; Nasopharyngeal Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms; Pituitary Neoplasms; Prostatic Neoplasms; Rectal Neoplasms; Retroviridae Infections; Salivary Gland Neoplasms; Sarcoma, Kaposi; Sarcoma, Synovial; Stomach Neoplasms; Thyroid Neoplasms; Urinary Bladder Neoplasms; Adenocarcinoma of Lung; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Glioblastoma; Head and Neck Neoplasms; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Mesothelioma; Prostatic Neoplasms, Castration-Resistant; Sarcoma; Small Cell Lung Carcinoma; Urogenital Neoplasms; Melanoma; Neoplasms

Cytotoxic T-lymphocyte protein 4 inhibitor


Antibody Approved CANCER; OTHER INJECTION Hematologic Neoplasms; Leukemia; Leukemia, Myeloid, Acute; Lymphoma, T-Cell, Cutaneous; Enteropathy-Associated T-Cell Lymphoma; Graft vs Host Disease; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Mast-Cell; Lupus Erythematosus, Systemic; Lymphoma; Lymphoma, Follicular; Lymphoma, T-Cell, Peripheral; Mesothelioma; Neoplasms, Germ Cell and Embryonal; Scleroderma, Diffuse; Sezary Syndrome; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Mycosis Fungoides; Hodgkin Disease; Lymphoma, Large-Cell, Anaplastic; Neoplasms Tubulin inhibitor

Antibody

Approved

CANCER; OTHER

INJECTION

Hematologic Neoplasms; Leukemia; Leukemia, Myeloid, Acute; Lymphoma, T-Cell, Cutaneous; Enteropathy-Associated T-Cell Lymphoma; Graft vs Host Disease; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Mast-Cell; Lupus Erythematosus, Systemic; Lymphoma; Lymphoma, Follicular; Lymphoma, T-Cell, Peripheral; Mesothelioma; Neoplasms, Germ Cell and Embryonal; Scleroderma, Diffuse; Sezary Syndrome; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Mycosis Fungoides; Hodgkin Disease; Lymphoma, Large-Cell, Anaplastic; Neoplasms

Tubulin inhibitor


Antibody Approved OTHER IV (INFUSION) Anthrax Protective antigen binding agent


Antibody Approved PREGNANCY AND GYNECOLOGY SINGLE-USE Breast Neoplasms, Male; Colonic Neoplasms; Esophageal Neoplasms; Rectal Neoplasms; Carcinoma, Neuroendocrine; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Fallopian Tube Neoplasms; Hemangiosarcoma; Neoplasm Metastasis; Pancreatic Neoplasms; Peritoneal Neoplasms; Prostatic Neoplasms, Castration-Resistant; Inflammatory Breast Neoplasms; Ovarian Neoplasms; Stomach Neoplasms; Breast Neoplasms; Neoplasms Receptor protein-tyrosine kinase erbB-2 inhibitor

Antibody

Approved

PREGNANCY AND GYNECOLOGY

SINGLE-USE

Breast Neoplasms, Male; Colonic Neoplasms; Esophageal Neoplasms; Rectal Neoplasms; Carcinoma, Neuroendocrine; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Fallopian Tube Neoplasms; Hemangiosarcoma; Neoplasm Metastasis; Pancreatic Neoplasms; Peritoneal Neoplasms; Prostatic Neoplasms, Castration-Resistant; Inflammatory Breast Neoplasms; Ovarian Neoplasms; Stomach Neoplasms; Breast Neoplasms; Neoplasms

Receptor protein-tyrosine kinase erbB-2 inhibitor


Antibody Approved CANCER INJECTION Burkitt Lymphoma; Colorectal Neoplasms; Hodgkin Disease; Leukemia; Leukemia, Prolymphocytic; Mycosis Fungoides; Renal Insufficiency, Chronic; Carcinoma, Non-Small-Cell Lung; Graft vs Host Disease; Leukemia, Hairy Cell; Lymphoma; Lymphoma, Mantle-Cell; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Waldenstrom Macroglobulinemia; Kidney Diseases; Lupus Erythematosus, Systemic; Lupus Nephritis; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Follicular; Neoplasms B-lymphocyte antigen CD20 binding agent

Antibody

Approved

CANCER

INJECTION

Burkitt Lymphoma; Colorectal Neoplasms; Hodgkin Disease; Leukemia; Leukemia, Prolymphocytic; Mycosis Fungoides; Renal Insufficiency, Chronic; Carcinoma, Non-Small-Cell Lung; Graft vs Host Disease; Leukemia, Hairy Cell; Lymphoma; Lymphoma, Mantle-Cell; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Waldenstrom Macroglobulinemia; Kidney Diseases; Lupus Erythematosus, Systemic; Lupus Nephritis; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Follicular; Neoplasms

B-lymphocyte antigen CD20 binding agent


Antibody Approved Unknown Unknown Carcinoma, Non-Small-Cell Lung; Multiple Myeloma; Neoplasm Metastasis; Ovarian Neoplasms; Salivary Gland Neoplasms; Stomach Neoplasms; Breast Neoplasms; Neoplasms Receptor protein-tyrosine kinase erbB-2 inhibitor


Antibody Approved CANCER INJECTION Multiple Myeloma; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Hematologic Neoplasms; Leukemia, Biphenotypic, Acute; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Neoplasms; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma B-lymphocyte antigen CD19 cross-linking agent


Antibody Approved DERMATOLOGY UNKNOWN Carcinoma, Intraductal, Noninfiltrating; Smoldering Multiple Myeloma; Carcinoma, Basal Cell; Glioma; HIV Infections; Leukemia; Leukemia, Biphenotypic, Acute; Leukemia, Lymphoid; Liver Neoplasms; Lymphoma, Mantle-Cell; Lymphoma, T-Cell, Cutaneous; Lymphoma, T-Cell, Peripheral; Neuroblastoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Uterine Neoplasms; Adrenal Cortex Neoplasms; Anus Neoplasms; Biliary Tract Neoplasms; Brain Neoplasms; Breast Neoplasms, Male; Carcinoid Tumor; Carcinoma, Adenoid Cystic; Carcinoma in Situ; Carcinoma, Medullary; Carcinoma, Neuroendocrine; Carcinoma, Pancreatic Ductal; Cholangiocarcinoma; Colonic Neoplasms; Gallbladder Neoplasms; Gastrointestinal Stromal Tumors; Genital Neoplasms, Female; Gestational Trophoblastic Disease; Glioblastoma; Gliosarcoma; Granuloma, Lethal Midline; Hemangiosarcoma; Hematologic Neoplasms; Hereditary Breast and Ovarian Cancer Syndrome; Inflammatory Breast Neoplasms; Kidney Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Leukoplakia; Leukoplakia, Oral; Lymphoma; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Meningeal Carcinomatosis; Meningeal Neoplasms; Meningioma; Mouth Neoplasms; Mycosis Fungoides; Myelodysplastic Syndromes; Neoplasm Metastasis; Neurilemmoma; Neuroendocrine Tumors; Oropharyngeal Neoplasms; Osteosarcoma; Pancreatic Neoplasms; Papilloma; Parotid Neoplasms; Penile Neoplasms; Pneumonia, Viral; Rectal Neoplasms; Salivary Gland Neoplasms; Sarcoma; Sarcoma, Alveolar Soft Part; Sarcoma, Kaposi; Scleroderma, Systemic; Severe Acute Respiratory Syndrome; Sezary Syndrome; Skin Neoplasms; Squamous Cell Carcinoma of Head and Neck; Thymoma; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Triple Negative Breast Neoplasms; Vulvar Neoplasms; Waldenstrom Macroglobulinemia; Adenocarcinoma of Lung; Breast Carcinoma In Situ; Breast Neoplasms; Carcinoma; Carcinoma, Hepatocellular; Carcinoma, Merkel Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Colorectal Neoplasms; Endometrial Neoplasms; Esophageal Neoplasms; Fallopian Tube Neoplasms; Head and Neck Neoplasms; Hodgkin Disease; Lung Neoplasms; Mesothelioma; Multiple Myeloma; Nasopharyngeal Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Small Cell Lung Carcinoma; Stomach Neoplasms; Urinary Bladder Neoplasms; Urogenital Neoplasms; Uterine Cervical Neoplasms; Melanoma; Neoplasms Programmed cell death protein 1 inhibitor

Antibody

Approved

DERMATOLOGY

UNKNOWN

Carcinoma, Intraductal, Noninfiltrating; Smoldering Multiple Myeloma; Carcinoma, Basal Cell; Glioma; HIV Infections; Leukemia; Leukemia, Biphenotypic, Acute; Leukemia, Lymphoid; Liver Neoplasms; Lymphoma, Mantle-Cell; Lymphoma, T-Cell, Cutaneous; Lymphoma, T-Cell, Peripheral; Neuroblastoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Uterine Neoplasms; Adrenal Cortex Neoplasms; Anus Neoplasms; Biliary Tract Neoplasms; Brain Neoplasms; Breast Neoplasms, Male; Carcinoid Tumor; Carcinoma, Adenoid Cystic; Carcinoma in Situ; Carcinoma, Medullary; Carcinoma, Neuroendocrine; Carcinoma, Pancreatic Ductal; Cholangiocarcinoma; Colonic Neoplasms; Gallbladder Neoplasms; Gastrointestinal Stromal Tumors; Genital Neoplasms, Female; Gestational Trophoblastic Disease; Glioblastoma; Gliosarcoma; Granuloma, Lethal Midline; Hemangiosarcoma; Hematologic Neoplasms; Hereditary Breast and Ovarian Cancer Syndrome; Inflammatory Breast Neoplasms; Kidney Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Leukoplakia; Leukoplakia, Oral; Lymphoma; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Meningeal Carcinomatosis; Meningeal Neoplasms; Meningioma; Mouth Neoplasms; Mycosis Fungoides; Myelodysplastic Syndromes; Neoplasm Metastasis; Neurilemmoma; Neuroendocrine Tumors; Oropharyngeal Neoplasms; Osteosarcoma; Pancreatic Neoplasms; Papilloma; Parotid Neoplasms; Penile Neoplasms; Pneumonia, Viral; Rectal Neoplasms; Salivary Gland Neoplasms; Sarcoma; Sarcoma, Alveolar Soft Part; Sarcoma, Kaposi; Scleroderma, Systemic; Severe Acute Respiratory Syndrome; Sezary Syndrome; Skin Neoplasms; Squamous Cell Carcinoma of Head and Neck; Thymoma; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Triple Negative Breast Neoplasms; Vulvar Neoplasms; Waldenstrom Macroglobulinemia; Adenocarcinoma of Lung; Breast Carcinoma In Situ; Breast Neoplasms; Carcinoma; Carcinoma, Hepatocellular; Carcinoma, Merkel Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Colorectal Neoplasms; Endometrial Neoplasms; Esophageal Neoplasms; Fallopian Tube Neoplasms; Head and Neck Neoplasms; Hodgkin Disease; Lung Neoplasms; Mesothelioma; Multiple Myeloma; Nasopharyngeal Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Small Cell Lung Carcinoma; Stomach Neoplasms; Urinary Bladder Neoplasms; Urogenital Neoplasms; Uterine Cervical Neoplasms; Melanoma; Neoplasms

Programmed cell death protein 1 inhibitor


Antibody Approved GASTROINTESTINAL; OTHER INJECTION Desmoplastic Small Round Cell Tumor; Glioma; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Sarcoma, Synovial; Adenocarcinoma; Biliary Tract Neoplasms; Carcinoid Tumor; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Cholangiocarcinoma; Colonic Neoplasms; Esophageal Neoplasms; Gallbladder Neoplasms; Glioblastoma; Melanoma; Mesothelioma; Pancreatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Rectal Neoplasms; Thymoma; Breast Neoplasms; Carcinoma, Hepatocellular; Colorectal Neoplasms; Stomach Neoplasms; Urinary Bladder Neoplasms; Carcinoma, Non-Small-Cell Lung; Neoplasms Vascular endothelial growth factor receptor 2 inhibitor

Antibody

Approved

GASTROINTESTINAL; OTHER

INJECTION

Desmoplastic Small Round Cell Tumor; Glioma; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Sarcoma, Synovial; Adenocarcinoma; Biliary Tract Neoplasms; Carcinoid Tumor; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Cholangiocarcinoma; Colonic Neoplasms; Esophageal Neoplasms; Gallbladder Neoplasms; Glioblastoma; Melanoma; Mesothelioma; Pancreatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Rectal Neoplasms; Thymoma; Breast Neoplasms; Carcinoma, Hepatocellular; Colorectal Neoplasms; Stomach Neoplasms; Urinary Bladder Neoplasms; Carcinoma, Non-Small-Cell Lung; Neoplasms

Vascular endothelial growth factor receptor 2 inhibitor


Antibody Approved GASTROINTESTINAL INJECTION HIV Infections; Inflammatory Bowel Diseases; Melanoma; Celiac Disease; Colitis; Infections; Colitis, Ulcerative; Crohn Disease; Immune System Diseases Integrin alpha-4/beta-7 inhibitor


Antibody Approved IMMUNE SYSTEM; OTHER INJECTION Diabetes Mellitus, Type 1; Carcinoma, Renal Cell; Paraproteinemias; Schizophrenia; Kidney Neoplasms; Myelodysplastic Syndromes; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Multiple Myeloma; Severe Acute Respiratory Syndrome; Castleman Disease; Immune System Diseases Interleukin-6 inhibitor


Antibody Approved Unknown INJECTION Glioblastoma; Carcinoma, Non-Small-Cell Lung; Heart Failure; Sepsis; ST Elevation Myocardial Infarction; Acute Coronary Syndrome; Hypercholesterolemia; Hyperlipidemia, Familial Combined; Hyperlipidemias; Lipid Metabolism Disorders; Severe Acute Respiratory Syndrome; Cardiovascular Diseases; Coronary Artery Disease; Coronary Disease; Hyperlipoproteinemia Type II; Myocardial Infarction; Stroke Subtilisin/kexin type 9 inhibitor

Antibody

Approved

Unknown

INJECTION

Glioblastoma; Carcinoma, Non-Small-Cell Lung; Heart Failure; Sepsis; ST Elevation Myocardial Infarction; Acute Coronary Syndrome; Hypercholesterolemia; Hyperlipidemia, Familial Combined; Hyperlipidemias; Lipid Metabolism Disorders; Severe Acute Respiratory Syndrome; Cardiovascular Diseases; Coronary Artery Disease; Coronary Disease; Hyperlipoproteinemia Type II; Myocardial Infarction; Stroke

Subtilisin/kexin type 9 inhibitor


Antibody Approved Unknown INTRA-ARTICULAR; INTRAMUSCULAR; INTRAVITREAL Neoplasm Metastasis; Carcinoma, Squamous Cell; Carcinoma, Non-Small-Cell Lung; Neoplasms Epidermal growth factor receptor erbB1 inhibitor


Antibody Approved Unknown INJECTION Amyloidosis, Familial; Hematologic Neoplasms; Immunoglobulin G4-Related Disease; Leukemia, Plasma Cell; Smoldering Multiple Myeloma; Multiple Myeloma; Neoplasms SLAM family member 7 inhibitor


Antibody Approved Unknown INTRAVENOUS Ganglioneuroblastoma; Osteosarcoma; Small Cell Lung Carcinoma; Neoplasms; Neuroblastoma Disialoganglioside GD2 binding agent


Antibody Approved RESPIRATORY INJECTION Diffuse Intrinsic Pontine Glioma; Genital Neoplasms, Female; Hepatitis D; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphoma, Mantle-Cell; Lymphoma, T-Cell; Mycosis Fungoides; Neoplasm Metastasis; Nerve Sheath Neoplasms; Neuroblastoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retroperitoneal Neoplasms; Sepsis; Sezary Syndrome; Triple Negative Breast Neoplasms; Adenocarcinoma; Adrenal Cortex Neoplasms; Basal Cell Nevus Syndrome; Biliary Tract Neoplasms; Carcinoid Tumor; Carcinoma; Carcinoma, Basal Cell; Carcinoma, Large Cell; Carcinoma, Merkel Cell; Carcinoma, Neuroendocrine; Carcinoma, Pancreatic Ductal; Carcinoma, Small Cell; Cholangiocarcinoma; Chordoma; Colonic Neoplasms; Colorectal Neoplasms; Endometrial Neoplasms; Fallopian Tube Neoplasms; Gastrointestinal Stromal Tumors; Glioma; Gliosarcoma; Hemangiosarcoma; Hematologic Neoplasms; Hepatitis B, Chronic; Histiocytoma, Malignant Fibrous; Inflammatory Breast Neoplasms; Leiomyosarcoma; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Leukoplakia, Oral; Liposarcoma; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Peripheral; Meningioma; Myelodysplastic Syndromes; Nasopharyngeal Neoplasms; Neoplasms, Germ Cell and Embryonal; Oligodendroglioma; Oropharyngeal Neoplasms; Osteosarcoma; Ovarian Neoplasms; Pancreatic Neoplasms; Peritoneal Neoplasms; Pituitary Neoplasms; Pneumonia, Viral; Prostatic Neoplasms; Pulmonary Disease, Chronic Obstructive; Rectal Neoplasms; Retroviridae Infections; Salivary Gland Neoplasms; Sarcoma, Kaposi; Severe Acute Respiratory Syndrome; Small Cell Lung Carcinoma; Squamous Cell Carcinoma of Head and Neck; Thyroid Neoplasms; Uterine Cervical Neoplasms; Adenocarcinoma of Lung; Brain Neoplasms; Breast Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Squamous Cell; Esophageal Neoplasms; Glioblastoma; Head and Neck Neoplasms; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Lymphoma, Follicular; Mesothelioma; Multiple Myeloma; Prostatic Neoplasms, Castration-Resistant; Sarcoma; Skin Neoplasms; Stomach Neoplasms; Urinary Bladder Neoplasms; Urogenital Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Hodgkin Disease; Melanoma; Neoplasms Programmed cell death protein 1 inhibitor

Antibody

Approved

RESPIRATORY

INJECTION

Diffuse Intrinsic Pontine Glioma; Genital Neoplasms, Female; Hepatitis D; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphoma, Mantle-Cell; Lymphoma, T-Cell; Mycosis Fungoides; Neoplasm Metastasis; Nerve Sheath Neoplasms; Neuroblastoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retroperitoneal Neoplasms; Sepsis; Sezary Syndrome; Triple Negative Breast Neoplasms; Adenocarcinoma; Adrenal Cortex Neoplasms; Basal Cell Nevus Syndrome; Biliary Tract Neoplasms; Carcinoid Tumor; Carcinoma; Carcinoma, Basal Cell; Carcinoma, Large Cell; Carcinoma, Merkel Cell; Carcinoma, Neuroendocrine; Carcinoma, Pancreatic Ductal; Carcinoma, Small Cell; Cholangiocarcinoma; Chordoma; Colonic Neoplasms; Colorectal Neoplasms; Endometrial Neoplasms; Fallopian Tube Neoplasms; Gastrointestinal Stromal Tumors; Glioma; Gliosarcoma; Hemangiosarcoma; Hematologic Neoplasms; Hepatitis B, Chronic; Histiocytoma, Malignant Fibrous; Inflammatory Breast Neoplasms; Leiomyosarcoma; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Leukoplakia, Oral; Liposarcoma; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Peripheral; Meningioma; Myelodysplastic Syndromes; Nasopharyngeal Neoplasms; Neoplasms, Germ Cell and Embryonal; Oligodendroglioma; Oropharyngeal Neoplasms; Osteosarcoma; Ovarian Neoplasms; Pancreatic Neoplasms; Peritoneal Neoplasms; Pituitary Neoplasms; Pneumonia, Viral; Prostatic Neoplasms; Pulmonary Disease, Chronic Obstructive; Rectal Neoplasms; Retroviridae Infections; Salivary Gland Neoplasms; Sarcoma, Kaposi; Severe Acute Respiratory Syndrome; Small Cell Lung Carcinoma; Squamous Cell Carcinoma of Head and Neck; Thyroid Neoplasms; Uterine Cervical Neoplasms; Adenocarcinoma of Lung; Brain Neoplasms; Breast Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Squamous Cell; Esophageal Neoplasms; Glioblastoma; Head and Neck Neoplasms; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Lymphoma, Follicular; Mesothelioma; Multiple Myeloma; Prostatic Neoplasms, Castration-Resistant; Sarcoma; Skin Neoplasms; Stomach Neoplasms; Urinary Bladder Neoplasms; Urogenital Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Hodgkin Disease; Melanoma; Neoplasms

Programmed cell death protein 1 inhibitor


Antibody Approved IMMUNE SYSTEM INJECTION Pityriasis Rubra Pilaris; Rosacea; Alopecia Areata; Asthma; Crohn Disease; Dermatitis, Atopic; Diabetes Mellitus, Type 1; Dry Eye Syndromes; Lupus Erythematosus, Discoid; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Necrobiosis Lipoidica; Polymyalgia Rheumatica; Pyoderma; Tendinopathy; Arthritis, Rheumatoid; Behcet Syndrome; Giant Cell Arteritis; Graves Ophthalmopathy; Hidradenitis Suppurativa; Lupus Nephritis; Osteoarthritis; Spondylitis, Ankylosing; Uveitis; Arthritis, Psoriatic; Immune System Diseases; Psoriasis; Spondylarthropathies Interleukin 17A inhibitor

Antibody

Approved

IMMUNE SYSTEM

INJECTION

Pityriasis Rubra Pilaris; Rosacea; Alopecia Areata; Asthma; Crohn Disease; Dermatitis, Atopic; Diabetes Mellitus, Type 1; Dry Eye Syndromes; Lupus Erythematosus, Discoid; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Necrobiosis Lipoidica; Polymyalgia Rheumatica; Pyoderma; Tendinopathy; Arthritis, Rheumatoid; Behcet Syndrome; Giant Cell Arteritis; Graves Ophthalmopathy; Hidradenitis Suppurativa; Lupus Nephritis; Osteoarthritis; Spondylitis, Ankylosing; Uveitis; Arthritis, Psoriatic; Immune System Diseases; Psoriasis; Spondylarthropathies

Interleukin 17A inhibitor


Antibody Approved Unknown INJECTION Atherosclerosis; Diabetes Mellitus; Hypercholesterolemia; Lipid Metabolism Disorders; Cardiovascular Diseases; Coronary Artery Disease; Coronary Disease; Hyperlipoproteinemia Type II Subtilisin/kexin type 9 inhibitor


Antibody Approved Unknown INJECTION Hemorrhage Dabigatran sequestering agent


Antibody Approved Unknown INJECTION Carcinoma, Renal Cell; Carcinoma, Non-Small-Cell Lung; Glioblastoma; Graft vs Host Disease; Hodgkin Disease; Leukemia, Plasma Cell; Lymphoma, Non-Hodgkin; Mycosis Fungoides; Prostatic Neoplasms; Alzheimer Disease; Amyloidosis, Familial; Colorectal Neoplasms; Leukemia, Biphenotypic, Acute; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Lupus Erythematosus, Systemic; Lupus Nephritis; Lymphoma; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Myelodysplastic Syndromes; Paraproteinemias; Plasmacytoma; POEMS Syndrome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prostatic Neoplasms, Castration-Resistant; Purpura, Thrombocytopenic, Idiopathic; Waldenstrom Macroglobulinemia; Amyloidosis; Smoldering Multiple Myeloma; Multiple Myeloma; Neoplasms Lymphocyte differentiation antigen CD38 inhibitor

Antibody

Approved

Unknown

INJECTION

Carcinoma, Renal Cell; Carcinoma, Non-Small-Cell Lung; Glioblastoma; Graft vs Host Disease; Hodgkin Disease; Leukemia, Plasma Cell; Lymphoma, Non-Hodgkin; Mycosis Fungoides; Prostatic Neoplasms; Alzheimer Disease; Amyloidosis, Familial; Colorectal Neoplasms; Leukemia, Biphenotypic, Acute; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Lupus Erythematosus, Systemic; Lupus Nephritis; Lymphoma; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Myelodysplastic Syndromes; Paraproteinemias; Plasmacytoma; POEMS Syndrome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prostatic Neoplasms, Castration-Resistant; Purpura, Thrombocytopenic, Idiopathic; Waldenstrom Macroglobulinemia; Amyloidosis; Smoldering Multiple Myeloma; Multiple Myeloma; Neoplasms

Lymphocyte differentiation antigen CD38 inhibitor


Antibody Unknown Unknown Unknown Urticaria; Dermatitis, Atopic; Eosinophilia; Eosinophilic Esophagitis; Churg-Strauss Syndrome; Nasal Polyps; Pulmonary Disease, Chronic Obstructive; Asthma; Chronic Disease; Hypereosinophilic Syndrome; Lung Diseases, Obstructive; Systemic Vasculitis Interleukin-5 inhibitor


Antibody Approved Unknown INJECTION Arthritis, Rheumatoid; Diabetes Mellitus, Type 1; Pemphigoid, Bullous; Pityriasis Rubra Pilaris; Pyoderma; Severe Acute Respiratory Syndrome; Spondylitis, Ankylosing; Arthritis, Psoriatic; Immune System Diseases; Psoriasis Interleukin 17A inhibitor


Antibody Approved Unknown INJECTION Bronchitis; Hypereosinophilic Syndrome; Loiasis; Eosinophilic Esophagitis; Sinusitis; Substance-Related Disorders; Asthma; Lung Diseases, Obstructive Interleukin-5 inhibitor


Antibody Approved Unknown INJECTION Clostridium Infections Toxin B inhibitor


Antibody Approved Unknown INJECTION Anthrax Protective antigen binding agent

Antibody

Approved

Unknown

INJECTION

Glioma; Gliosarcoma; Hematologic Neoplasms; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Liver Neoplasms; Lymphoma, Non-Hodgkin; Multiple Myeloma; Myelodysplastic Syndromes; Skin Neoplasms; Anus Neoplasms; Biliary Tract Neoplasms; Carcinoma; Carcinoma, Pancreatic Ductal; Cholangiocarcinoma; Glioblastoma; Head and Neck Neoplasms; Hodgkin Disease; Kidney Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Mycosis Fungoides; Neoplasm Metastasis; Pancreatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Rectal Neoplasms; Retroviridae Infections; Sarcoma; Sarcoma, Alveolar Soft Part; Sezary Syndrome; Stomach Neoplasms; Thyroid Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Colorectal Neoplasms; Endometrial Neoplasms; Esophageal Neoplasms; Fallopian Tube Neoplasms; Melanoma; Mesothelioma; Ovarian Neoplasms; Peritoneal Neoplasms; Prostatic Neoplasms; Small Cell Lung Carcinoma; Triple Negative Breast Neoplasms; Urinary Bladder Neoplasms; Urogenital Neoplasms; Uterine Cervical Neoplasms; Breast Neoplasms; Carcinoma, Transitional Cell; Lung Neoplasms; Neoplasms

Programmed cell death 1 ligand 1 inhibitor


Antibody Approved Unknown INJECTION Leiomyosarcoma; Neoplasm Metastasis; Pancreatic Neoplasms; Carcinoma, Non-Small-Cell Lung; Gastrointestinal Stromal Tumors; Glioblastoma; Ovarian Neoplasms; Prostatic Neoplasms, Castration-Resistant; Neoplasms; Sarcoma Platelet-derived growth factor receptor alpha antagonist

Antibody

Approved

Unknown

INJECTION

Hematologic Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Follicular; Lymphoma, T-Cell, Cutaneous; Melanoma; Neoplasm Metastasis; Plasmacytoma; Polycythemia Vera; Primary Myelofibrosis; Skin Neoplasms; Triple Negative Breast Neoplasms; Adenocarcinoma; Adenocarcinoma, Clear Cell; Adenocarcinoma, Follicular; Adenocarcinoma of Lung; Anus Neoplasms; Bile Duct Neoplasms; Breast Neoplasms; Carcinoma; Carcinoma, Large Cell; Carcinoma, Pancreatic Ductal; Cholangiocarcinoma; Colorectal Neoplasms; Dysgerminoma; Fallopian Tube Neoplasms; Genital Neoplasms, Female; Glioblastoma; Head and Neck Neoplasms; Hemangiosarcoma; Leukemia, Myeloid, Acute; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Mouth Neoplasms; Multiple Myeloma; Myelodysplastic Syndromes; Neoplasms, Germ Cell and Embryonal; Neuroendocrine Tumors; Pancreatic Neoplasms; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Rectal Neoplasms; Sarcoma; Seminoma; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Thyroid Neoplasms; Biliary Tract Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Endometrial Neoplasms; Esophageal Neoplasms; Mesothelioma; Oropharyngeal Neoplasms; Ovarian Neoplasms; Urogenital Neoplasms; Uterine Cervical Neoplasms; Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Neoplasms; Small Cell Lung Carcinoma; Urinary Bladder Neoplasms

Programmed cell death 1 ligand 1 inhibitor


Antibody Approved Unknown UNKNOWN Blast Crisis; Hematologic Neoplasms; Leukemia, Biphenotypic, Acute; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Neoplasms; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma CD22 binding agent


Antibody Approved Unknown INJECTION Hemophilia A; Hemorrhage Coagulation factor IX and X other


Antibody Approved Unknown INJECTION Scleroderma, Systemic; Arthritis, Rheumatoid; Asthma; Crohn Disease; Hidradenitis Suppurativa; Arthritis, Psoriatic; Spondylitis, Ankylosing; Immune System Diseases; Psoriasis Interleukin-17 receptor A antagonist


Antibody Approved Unknown INJECTION Scleroderma, Localized; Arthritis, Juvenile; Mastocytosis, Systemic; Spondylitis, Ankylosing; Uveitis; Giant Cell Arteritis; Polymyalgia Rheumatica; Severe Acute Respiratory Syndrome; Arthritis, Rheumatoid; Immune System Diseases Interleukin-6 receptor alpha subunit antagonist

Antibody

Approved

Unknown

INJECTION; INTRAVENOUS

Carcinoma, Pancreatic Ductal; Chordoma; Fallopian Tube Neoplasms; Glioma; Head and Neck Neoplasms; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Melanoma; Meningioma; Mesothelioma; Peritoneal Neoplasms; Prostatic Neoplasms; Skin Neoplasms; Adenocarcinoma; Carcinoma, Adenoid Cystic; Carcinoma, Hepatocellular; Carcinoma, Neuroendocrine; Colorectal Neoplasms; Endometrial Neoplasms; Esophageal Neoplasms; Gestational Trophoblastic Disease; Glioblastoma; Hemangiosarcoma; Hodgkin Disease; Leiomyosarcoma; Lymphoma; Multiple Myeloma; Nasopharyngeal Neoplasms; Neuroendocrine Tumors; Osteosarcoma; Pancreatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Rectal Neoplasms; Small Cell Lung Carcinoma; Thymoma; Urinary Bladder Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Colonic Neoplasms; Lymphoma, Large B-Cell, Diffuse; Ovarian Neoplasms; Stomach Neoplasms; Urogenital Neoplasms; Carcinoma, Merkel Cell; Carcinoma, Transitional Cell; Neoplasms

Programmed cell death 1 ligand 1 other

Antibody

Approved

Unknown

INJECTION

Alopecia Areata; Angioedema; Conjunctivitis, Allergic; Netherton Syndrome; Peanut Hypersensitivity; Pemphigoid, Bullous; Prostatic Neoplasms, Castration-Resistant; Pruritus; Respiratory Tract Diseases; Rhinitis, Allergic, Seasonal; Scleroderma, Localized; Severe Acute Respiratory Syndrome; Aspergillosis, Allergic Bronchopulmonary; Asthma; Dermatitis; Eosinophilic Esophagitis; Neurodermatitis; Pulmonary Disease, Chronic Obstructive; Sinusitis; Urticaria; Dermatitis, Atopic; Eczema; Nasal Polyps

Interleukin-4 receptor subunit alpha antagonist


Antibody Approved Unknown INJECTION Dermatitis, Atopic; Hematologic Diseases; Sinusitis; Urticaria; Eosinophilic Esophagitis; Hypereosinophilic Syndrome; Nasal Polyps; Pemphigoid, Bullous; Pulmonary Disease, Chronic Obstructive; Asthma; Lung Diseases, Obstructive Interleukin-5 receptor subunit alpha inhibitor